JP2015517520A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015517520A5 JP2015517520A5 JP2015512636A JP2015512636A JP2015517520A5 JP 2015517520 A5 JP2015517520 A5 JP 2015517520A5 JP 2015512636 A JP2015512636 A JP 2015512636A JP 2015512636 A JP2015512636 A JP 2015512636A JP 2015517520 A5 JP2015517520 A5 JP 2015517520A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- subject
- cells
- cell
- brain injury
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims description 33
- 102000040430 polynucleotide Human genes 0.000 claims description 21
- 108091033319 polynucleotide Proteins 0.000 claims description 21
- 239000002157 polynucleotide Substances 0.000 claims description 21
- 230000001272 neurogenic effect Effects 0.000 claims description 15
- 208000030886 Traumatic Brain injury Diseases 0.000 claims description 13
- 208000029028 brain injury Diseases 0.000 claims description 13
- 230000009529 traumatic brain injury Effects 0.000 claims description 13
- 210000004556 brain Anatomy 0.000 claims description 12
- 102400000552 Notch 1 intracellular domain Human genes 0.000 claims description 11
- 101800001628 Notch 1 intracellular domain Proteins 0.000 claims description 11
- 102000005650 Notch Receptors Human genes 0.000 claims description 7
- 108010070047 Notch Receptors Proteins 0.000 claims description 7
- 238000004113 cell culture Methods 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 7
- 230000001939 inductive effect Effects 0.000 claims description 5
- 230000005012 migration Effects 0.000 claims description 3
- 238000013508 migration Methods 0.000 claims description 3
- 230000004936 stimulating effect Effects 0.000 claims description 3
- 238000002054 transplantation Methods 0.000 claims description 3
- 230000006931 brain damage Effects 0.000 claims 1
- 231100000874 brain damage Toxicity 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 38
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 12
- 230000035755 proliferation Effects 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261647893P | 2012-05-16 | 2012-05-16 | |
| US61/647,893 | 2012-05-16 | ||
| PCT/US2013/030895 WO2013172944A1 (en) | 2012-05-16 | 2013-03-13 | Methods and compositions for treatment of traumatic brain injury and for modulation of migration of neurogenic cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016184086A Division JP2016220694A (ja) | 2012-05-16 | 2016-09-21 | 外傷性脳損傷の処置のため、および神経因性細胞の移動の調節のための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015517520A JP2015517520A (ja) | 2015-06-22 |
| JP2015517520A5 true JP2015517520A5 (enExample) | 2015-10-29 |
| JP6134783B2 JP6134783B2 (ja) | 2017-05-24 |
Family
ID=48040424
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015512636A Active JP6134783B2 (ja) | 2012-05-16 | 2013-03-13 | 外傷性脳損傷の処置のため、および神経因性細胞の移動の調節のための方法および組成物 |
| JP2016184086A Pending JP2016220694A (ja) | 2012-05-16 | 2016-09-21 | 外傷性脳損傷の処置のため、および神経因性細胞の移動の調節のための方法および組成物 |
| JP2018082259A Pending JP2018111733A (ja) | 2012-05-16 | 2018-04-23 | 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物 |
| JP2021038508A Pending JP2021098738A (ja) | 2012-05-16 | 2021-03-10 | 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物 |
| JP2023078339A Pending JP2023099213A (ja) | 2012-05-16 | 2023-05-11 | 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物 |
| JP2025030492A Pending JP2025098021A (ja) | 2012-05-16 | 2025-02-27 | 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物 |
Family Applications After (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016184086A Pending JP2016220694A (ja) | 2012-05-16 | 2016-09-21 | 外傷性脳損傷の処置のため、および神経因性細胞の移動の調節のための方法および組成物 |
| JP2018082259A Pending JP2018111733A (ja) | 2012-05-16 | 2018-04-23 | 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物 |
| JP2021038508A Pending JP2021098738A (ja) | 2012-05-16 | 2021-03-10 | 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物 |
| JP2023078339A Pending JP2023099213A (ja) | 2012-05-16 | 2023-05-11 | 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物 |
| JP2025030492A Pending JP2025098021A (ja) | 2012-05-16 | 2025-02-27 | 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US9828593B2 (enExample) |
| EP (1) | EP2849766B1 (enExample) |
| JP (6) | JP6134783B2 (enExample) |
| CN (3) | CN109718250B (enExample) |
| AU (2) | AU2013263417B2 (enExample) |
| CA (1) | CA2872188C (enExample) |
| WO (1) | WO2013172944A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109718250B (zh) | 2012-05-16 | 2022-08-30 | 桑比欧公司 | 用于治疗创伤性脑损伤和用于调节神经原性细胞迁移的方法和组合物 |
| EP2906293B1 (en) | 2012-10-09 | 2018-12-12 | SanBio, Inc. | Methods and compositions for treatment of retinal degeneration |
| WO2015120388A1 (en) * | 2014-02-10 | 2015-08-13 | Cytori Therapeutics, Inc. | Regenerative cell therapy for central nervous system (cns) disorders and ptsd |
| CA2981523A1 (en) * | 2015-04-01 | 2016-10-06 | Sanbio, Inc. | Methods and compositions for stimulation of cell proliferation and provision of biologically active mixtures of fgf2 isoforms |
| KR101986366B1 (ko) * | 2016-02-26 | 2019-06-07 | 주식회사 이노퓨틱스 | Ｎｕｒｒ１과 Ｆｏｘａ２의 교질세포 기능 조절에 의한 염증성 신경질환 치료 |
| EP3423070B1 (en) * | 2016-03-03 | 2022-05-04 | Henry Ford Health System | 3-d collagen scaffold-generated exosomes and uses thereof |
| WO2018125829A1 (en) | 2016-12-28 | 2018-07-05 | Sanbio, Inc. | Cell delivery system and methods of operation thereof |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US20030003090A1 (en) | 2001-05-31 | 2003-01-02 | Prockop Darwin J. | Directed in vitro differentiation of marrow stromal cells into neural cell progenitors |
| JP3886346B2 (ja) | 2001-06-22 | 2007-02-28 | サンバイオ，インコーポレイティド | 骨髄間質細胞由来Ｓｃｈｗａｎｎ細胞を含む神経再生用医薬組成物 |
| CA2475288C (en) | 2002-02-06 | 2014-09-02 | Sanbio, Inc. | Method of inducing differentiation of bone marrow stromal cells to neural cells or skeletal muscle cells by introduction of notch gene |
| EP1635805A4 (en) | 2003-06-12 | 2007-08-08 | Ms Science Corp | SIGMA RECEPTOR LIGANDS FOR NEURONAL REGENERATION AND FUNCTIONAL RE-ESTABLISHMENT |
| KR20130062359A (ko) | 2004-04-12 | 2013-06-12 | 산바이오 인코포레이티드 | 뉴런의 전구 세포 특징들을 나타내는 세포 |
| EP1855700B1 (en) | 2005-03-07 | 2013-10-30 | SanBio, Inc. | Use of neuronal precursor cells for treatment of central nervous system lesions |
| CN101008033A (zh) * | 2006-01-27 | 2007-08-01 | 陈云 | 功能性中枢神经损伤诊断检测用基因芯片及其制造方法 |
| WO2008102460A1 (en) | 2007-02-23 | 2008-08-28 | Sanbio Inc. | Transplantation of bone marrow stromal cell-induced neural stem cells for promoting fuctional recovery after spinal cord injury |
| WO2009023251A1 (en) * | 2007-08-15 | 2009-02-19 | Sanbio, Inc. | Methods and compositions for treating neural degeneration |
| ES2787513T3 (es) | 2007-12-03 | 2020-10-16 | Sanbio Inc | Métodos y composiciones para modular la diferenciación de células pluripotenciales |
| US10702554B2 (en) | 2007-12-03 | 2020-07-07 | Sanbio, Inc. | Extracellular matrix from pluripotent cells |
| PL2274430T3 (pl) | 2008-04-30 | 2017-09-29 | Sanbio Inc | Komórki regenerujące nerwy ze zmianami w metylacji DNA |
| WO2012154344A1 (en) | 2011-04-06 | 2012-11-15 | Sanbio, Inc. | Methods and compositions for modulating peripheral immune function |
| US20120263681A1 (en) | 2011-04-12 | 2012-10-18 | Fujifilm Corporation | Composition comprising cell and biocompatible polymer |
| JP6306506B2 (ja) | 2011-08-19 | 2018-04-04 | サンバイオ，インコーポレイティド | 神経原生及びグリア原生因子及びそれらについてのアッセイ |
| JP6023218B2 (ja) | 2012-01-27 | 2016-11-09 | サンバイオ，インコーポレイティド | 血管新生及び血管発生を調節するための方法及び組成物 |
| CN109718250B (zh) * | 2012-05-16 | 2022-08-30 | 桑比欧公司 | 用于治疗创伤性脑损伤和用于调节神经原性细胞迁移的方法和组合物 |
-
2013
- 2013-03-13 CN CN201910165600.6A patent/CN109718250B/zh active Active
- 2013-03-13 CN CN202211044392.2A patent/CN115381855A/zh active Pending
- 2013-03-13 EP EP13713286.6A patent/EP2849766B1/en active Active
- 2013-03-13 CA CA2872188A patent/CA2872188C/en active Active
- 2013-03-13 US US13/800,585 patent/US9828593B2/en active Active
- 2013-03-13 AU AU2013263417A patent/AU2013263417B2/en active Active
- 2013-03-13 WO PCT/US2013/030895 patent/WO2013172944A1/en not_active Ceased
- 2013-03-13 CN CN201380025599.8A patent/CN104519891B/zh active Active
- 2013-03-13 JP JP2015512636A patent/JP6134783B2/ja active Active
-
2014
- 2014-09-18 US US14/489,934 patent/US20150197741A1/en not_active Abandoned
-
2016
- 2016-07-13 AU AU2016204910A patent/AU2016204910B2/en active Active
- 2016-09-21 JP JP2016184086A patent/JP2016220694A/ja active Pending
-
2018
- 2018-04-23 JP JP2018082259A patent/JP2018111733A/ja active Pending
-
2019
- 2019-02-26 US US16/285,700 patent/US10626389B2/en active Active
-
2020
- 2020-03-05 US US16/809,852 patent/US20200354709A1/en active Pending
-
2021
- 2021-03-10 JP JP2021038508A patent/JP2021098738A/ja active Pending
-
2023
- 2023-05-11 JP JP2023078339A patent/JP2023099213A/ja active Pending
-
2025
- 2025-02-27 JP JP2025030492A patent/JP2025098021A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2020047467A3 (en) | Cardiac cell reprogramming with myocardin and ascl1 | |
| MX2016005824A (es) | Metodo de cultivo celular. | |
| FI3186395T4 (fi) | Kantasolujen siirto kantasoluihin kohdistuvan aineen ja immunoregulatorisen signaloinnin modulaation yhdistelmällä | |
| MX2022015631A (es) | Anticuerpos anti-cd40 humanizados y usos de los mismos. | |
| MX2021003702A (es) | Uso de importadores de sustrato para la exportación de oligosacáridos. | |
| Matar et al. | Stem cell therapy for cardiac dysfunction | |
| WO2013013025A3 (en) | Anti-cxcr4 antibodies and methods of use | |
| SA522432139B1 (ar) | بروتينات ربط متعددة الخصوصية لمعالجة السرطان | |
| GB201315212D0 (en) | Systems, compositions and methods for transplantation | |
| WO2014089169A4 (en) | Immunotherapy with binding agents | |
| WO2016081032A3 (en) | Mesenchymal stem cells derived from induced pluripotent stem cells | |
| SG10201809146QA (en) | Recombinant host cell engineered to overexpress helper proteins | |
| JP2016501515A5 (enExample) | ||
| AU2018253575A1 (en) | Natural killer cells from placenta | |
| EA201270713A1 (ru) | Белки на основе фибронектина с каркасными доменами, которые связывают ил-23 | |
| Kelly et al. | TNF receptor 2, not TNF receptor 1 enhances mesenchymal stem cell-mediated cardiac protection following acute ischemia | |
| CA2929843A1 (en) | Methods of use for il-22 in the treatment of gastrointestinal graft vs. host disease | |
| WO2016063026A3 (en) | Selective nav protein binders | |
| EA201400401A1 (ru) | Биокомпозит для регенерации поврежденных тканей и органов, набор для изготовления биокомпозита и способ лечения | |
| JP2017536826A5 (enExample) | ||
| ZA202100888B (en) | Methods of preparing personalized blood vessels | |
| MX374489B (es) | Formulación de una composición sanguínea rica en plaquetas y/o factores de crecimiento, con proteínas gelificadas, y método de preparación de la misma. | |
| JP2017039729A5 (enExample) | ||
| EA201490995A1 (ru) | Использование фо-ти для усиления мобилизации и пролиферации стволовых клеток | |
| WO2015181831A3 (en) | A method for targettingglioblastoma with wharton jelly-mesenchymal stem cells (wj-msc) derived from human umbilical cord |